Rapid Malaria Test Kit

This kit is used for invitro qualitative detection of SARS‐CoV‐2 antigen. Positive result from the test need further analysis with clinical history of patient and other diagnostic information to determine patient's infection status. Positive value is only a reference guide for clinical diagnosis. The test results only reflect the current state of the sample. Negative result cannot exclude SARS‐CoV‐2 infection and should not be used as the sole basis for patient's management decisions. Negative results must be combined with clinical observations, patient history, and epidemiolol information. This test is only for clinical laboratories, medical institutions use and for real‐time inspection by professional medical staff, and not for home testing. It cannot be used as the basis for the diagnosis and exclusion of pneumonia caused by SARS‐CoV‐2 and is not suitable for general population screening. The laboratory testing of SARS‐CoV‐2 should meet the requirements of the "Laboratory testing for SARS‐CoV‐2 in suspected human cases” and other requirements, and pay attention to the biosecurity.

Rapid kala azar test is a medical device intended for the detection of kala azar antibody in blood/body fluids.

Dengue NS1 Antigen FP is a rapid solid phase immuno‐ chromatographic test for the qualitative detection of Dengue NS1 Antigen in human Whole Blood/ Serum/ Plasma. This test is for in vitro diagnostic use only and is intended as an aid in the earlier diagnosis of dengue infection.

Rapid Zika virus antibody test reagent/kit is a medical device intended for the detection of H.pylori Antibody in blood/body fluids.